Daiken Medical Co., Ltd. announced non-consolidated earnings results for the six months ended September 30, 2019. For the six months, the company reported net sales of ¥4,248 million against ¥4,195 million a year ago. Operating profit was ¥565 million against ¥705 million a year ago. Ordinary profit of ¥579 million against ¥703 million a year ago. Profit was ¥414 million or ¥14.42 per share against ¥485 million or ¥16.26 per share a year ago.

For the year, the company expects net sales of ¥8,500 million, operating profit of ¥1,280 million, ordinary profit of ¥1,300 million and profit of ¥870 million or ¥30.28 per share.